Showing results (1801-1810 of 3,615) with videos related to

Sort By:
Pageof 362
Journal of Viral Hepatitis|October 6, 2026
Finite Versus Indefinite Nucleos(t)ide Analogue Therapy in HBeAg‑Negative Chronic Hepatitis B: Meta‑Analysis of Randomized TrialsDemver P Gomez, Wilmyr F Hababag
Journal of Viral Hepatitis|December 10, 2014
Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infectionN Semmo, T Weber, J R Idle, et al.
Journal of Viral Hepatitis|October 21, 2015
Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countriesZ Younossi, A Brown, M Buti, et al.
Journal of Viral Hepatitis|July 29, 2015
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patientsJ Boursier, A Ducancelle, J Vergniol, et al.
Journal of Viral Hepatitis|April 30, 2016
Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort studyA Katoonizadeh, M Sharafkhah, M R Ostovaneh, et al.
Journal of Viral Hepatitis|March 4, 2016
Therapeutic outcome of 6198 interferon-naïve Egyptian patients with chronic hepatitis C: a real-life experience and lessons to be learned in DAAs' eraN Zayed, H Gamal Eldeen, H Elmakhzangy, et al.
Journal of Viral Hepatitis|July 5, 2014
rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patientsS J Chowdhury, V K Karra, P K Gumma, et al.
Journal of Viral Hepatitis|September 2, 2014
Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patientsL Barrett, N Trehanpati, S Poonia, et al.
Journal of Viral Hepatitis|August 28, 2014
Telomeric 1p36.3 deletion and Ki-67 expression in B-Non-Hodgkin's Lymphoma patients associated with chronic hepatitis C virus infectionE Mosad, M Said Abd El-Rahman Allam, H M Moustafa, et al.
Journal of Viral Hepatitis|June 9, 2012
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirinH Guedj, J Guedj, F Negro, et al.
Pageof 362